American Society for Radiation Oncology (ASTRO) — Event Research & Buyer Targeting Analysis

The American Society for Radiation Oncology (ASTRO) meeting (commonly referred to as the ASTRO Annual Meeting when describing the flagship event) is one of the largest global gatherings focused on radiation oncology—bringing together clinical leaders, researchers, clinicians, and technology/therapy innovators that support cancer care. For buyer-focused attendee research and audience targeting, this event is best treated as a medical specialty conference with a strong device + clinical workflow ecosystem rather than a general healthcare show.

Event Snapshot (for research positioning)

• Industry/Category: Healthcare, oncology, radiation oncology, medical devices, clinical research, radiation therapy technology
• Typical venue pattern: Rotates annually across major U.S. cities (and occasionally with strong international presence through participation)
• Event type: Clinical conference + scientific program + industry exhibits + symposia and education
• Buyer-relevant audience reality: Although ASTRO is clinically oriented, the “buyer influence” is strongly represented by hospital/health-system oncology leaders, radiation oncology department administrators, and technology evaluation teams.

1️⃣ Who attends (BUYERS / ATTENDEES)

ASTRO attracts both clinical attendees (radiation oncologists, residents/fellows, medical physicists, dosimetrists, radiation therapists) and commercially influential attendees who influence technology selection, clinical workflow decisions, and vendor engagement.

Primary attendee groups (what we should expect to see)

• Radiation Oncology clinicians: Medical oncologists specializing in radiation therapy, department chairs, division leaders, program directors
• Radiation oncology allied health: Medical physicists, dosimetrists, radiation therapists, clinical educators
• Clinical leadership & administrators: Practice administrators, oncology program managers, service line leaders, hospital leadership with oncology oversight
• Research & translational teams: Clinical trial investigators, research directors, academic research staff supporting radiation therapy studies
• Industry & solution stakeholders: Vendor clinical specialists, sales/proposal teams, market access personnel, field applications staff
• Health-system procurement influence: Buyers/contracting teams may be present indirectly via oncology tech evaluation teams or hospital operations leadership

Buyer-focused interpretation (most valuable “buyer influence” roles)

ASTRO is highly valuable for reaching buyers who evaluate and standardize radiation oncology technology and workflows. The strongest buyer-fit is typically concentrated in these decision layers:

• Department / Program leadership (chairs, directors, oncology program leaders)
• Clinical operations & service line management (program managers, heads of radiation oncology operations)
• Clinical technology evaluation teams (medical physicists, dosimetry leaders, clinical application leads)
• Vendor-adjacent “internal buyer influence” (clinical educators and workflow leads who shape adoption)
• Research leadership when the product is trials enablement, imaging workflows, analytics, or outcomes reporting

2️⃣ Where the show is happening + attendee geographic origin

ASTRO’s flagship meeting typically rotates across major U.S. cities. Even when the physical venue is in the United States, the attendee ecosystem is strongly international because radiation oncology is globally networked—especially through research collaboration and device evaluation.

Location

• Primary hosting pattern: Major U.S. exhibition/meeting venues
• Why this matters: Most institutions represented—community hospitals, academic medical centers, and integrated health systems—are U.S.-based, but global participation remains meaningful.

Attendee geographic origin (expected mix)

• U.S. dominance: Large majority of clinicians and healthcare decision-influencers come from the United States
• International presence: Meaningful contingent of attendees from Canada, Western Europe, and parts of Asia and other regions
• High concentration where radiation oncology networks exist: Academic centers and multinational medical technology ecosystem hubs

Best targeting geography strategy

• United States: Priority for U.S. health systems and academic centers
• Canada & Western Europe: Useful for internationally scaled vendors and global partnerships
• Research-heavy regions: Target countries with strong clinical trial participation and radiotherapy innovation adoption

3️⃣ Audience reach (Local / National / Global)

ASTRO has national reach (U.S.) with global reach across clinical research, radiation technology, and oncology care pathways. While it is not a “consumer” event, its reach is broad in the clinical + research ecosystem, which is often global in how practices and research adopt standards.

• Primary: National (U.S.)
• Secondary: International (global research and technology participation)
• Buyer density note: Buyer influence is concentrated among clinical leaders, physicists/dosimetry leaders, and health system oncology decision-makers

4️⃣ Sample buyer company names (BUYERS ONLY) + Websites

Below is a curated sample list of buyer-type organizations that are strong fits for radiation oncology technology, clinical workflows, imaging/therapy support, and oncology operational enablement. These are presented as “buyer accounts” because they either (a) operate treatment technology deployment through healthcare delivery, or (b) directly supply radiation oncology devices, solutions, and associated clinical technology ecosystems that actively evaluate and deploy solutions with clinical leaders.

Important: The best buyer fit depends on your client’s product. ASTRO can attract the right audience for medical devices, software/workflow tools, research platforms, treatment planning technologies, analytics, and clinical education—however, the “correct” buyer titles vary by product category.

5️⃣ Job profiles, industries & event type

Best job profiles to target at ASTRO

For buyer-relevant outreach, we prioritize titles that are either responsible for clinical decision-making, technology evaluation, service line oversight, or research adoption.

• Department leadership: Radiation Oncology Department Chair / Medical Director / Program Director
• Clinical operations leadership: Director, Radiation Oncology Services / Oncology Service Line Leader
• Technology evaluation roles: Chief Medical Physicist / Medical Physicist (Lead) / Dosimetry Lead
• Clinical technology adoption: Director of Clinical Applications / Clinical Workflow Lead / Technology Implementation Lead
• Research leadership: Director, Clinical Research / Research Program Director (oncology/radiation oncology)
• Procurement influence: Supply Chain Manager (Hospital/Health System) / Contracting Lead (when present through oncology operations teams)
• Therapy workflow education: Clinical Educator / Training Lead (radiation oncology)

Event type (how to classify it for targeting)

• Clinical Specialty Conference: radiation oncology education + research content
• Medical Technology & Innovation Show: vendors demonstrate devices and workflows
• Research & Standards Ecosystem: adoption depends on clinical evidence and workflow fit

Best Apollo-style industry filters (using your provided industry list)

Based on your provided industry list, the most relevant filters for ASTRO buyer targeting are typically:

• Hospital & Health Care
• Medical Practice
• Medical Devices
• Pharmaceuticals (more selectively; depends on your product)
• Biotechnology (especially for research enablement)
• Research (for analytics, trials, and evidence-generation)
• Renewables & Environment is generally not relevant; included here only as a reminder to avoid mismatched filters

6️⃣ Estimated attendance (expected total footfall)

ASTRO Annual Meeting attendance can vary year to year, but it is generally measured in the tens of thousands. For buyer targeting and audience research planning, we treat it as a high-attendance professional conference where:

• Scientific program participants and clinicians form the largest visible crowd
• Industry exhibit engagement concentrates around device evaluation and clinical workflow solutions
• Buyer density is not “mass retail buyer density,” but strong among oncology leadership and clinical technical decision influencers

Practical planning estimate: ~30,000–40,000+ total attendees (including exhibitors, clinicians, researchers, and allied health professionals).

7️⃣ Key focus areas & buyer engagement

ASTRO’s buyer engagement typically revolves around innovation adoption in radiation oncology and operational improvements that enable higher quality care. The “why vendors participate” is strongly tied to clinical evidence, technology performance, and workflow efficiency.

Key focus areas likely to dominate conversations

• Radiation therapy technology modernization (treatment delivery upgrades, workflow improvements)
• Precision treatment planning (planning, imaging integration, dosimetry workflow)
• Oncology care pathways (standardization across patient care journeys)
• Clinical evidence and outcomes (data-driven decision support and research enablement)
• Operational efficiency (throughput, planning automation, training and quality assurance)
• Complex cases and advanced modalities (advanced planning and delivery needs)

Best buyer engagement angle

The most effective engagement frame is to connect your client’s offering to clinical adoption and operational impact. ASTRO attendees respond well to evidence-based claims and workflow practicality.

• “We support radiation oncology departments with solutions that improve planning accuracy, workflow efficiency, training, and patient outcomes.”
• “We help clinical leaders evaluate and implement radiation oncology innovations with measurable operational and evidence-based benefits.”

8️⃣ Client-product fit & “who to prioritize” (based on your product)

We can recommend the best buyer types for ASTRO, but we need to map them precisely to your client’s product category. Please share the client website URL (and product name/one-line description) so we can determine:

• Which ASTRO buyer segments are most aligned (devices vs. software vs. services vs. research enablement)
• The exact job titles to prioritize (clinical leadership vs. physics/dosimetry vs. operations vs. research)
• Which healthcare organization types matter most for your client (academic centers vs. community health systems vs. specialty oncology groups)
• Whether to emphasize U.S.-only targeting or add Canada/International for higher match rates

How we would match buyers to common product categories (preview)

• If your client offers radiation therapy hardware / treatment delivery technology: prioritize Chief Medical Physicists, Dosimetry leads, Radiation Oncology Department leadership, clinical technology implementation leads.
• If your client offers treatment planning / imaging / dosimetry software: prioritize medical physicists, dosimetry leaders, clinical applications directors, research and workflow directors.
• If your client offers clinical analytics / outcomes / trials enablement: prioritize clinical research directors, oncology research leadership, data/clinical informatics roles (where applicable).
• If your client offers training / education or workflow services: prioritize radiation oncology operations leaders, training/education leads, and program directors.

Once we have your client website, we will refine the “best buyer fit” list and the titles to target accordingly.

9️⃣ Final recommendation (quality of ASTRO for buyer targeting)

ASTRO is typically a strong fit for medical device and radiation oncology workflow solutions, and also a strong fit for research enablement and clinical education products. The event’s quality comes from attendee relevance: the audience is concentrated in radiation oncology and closely related stakeholders.

Recommended approach:

• Target clinical leadership + physics/dosimetry + radiation oncology operations roles
• Use industries: Hospital & Health Care, Medical Practice, Medical Devices, Research, selectively Biotechnology and Pharmaceuticals
• Focus outreach messaging on evidence, workflow efficiency, precision, outcomes, and operational implementation

Buyer targeting quality (planning estimate): 8/10 for radiation oncology product categories; lower only if the product is not clearly tied to radiation therapy workflows or oncology program operations.

Buyer Sample List (15–20) — Table with Priority, Company, Website, Best Title to Target, Why This is a Good Buyer Fit

The table below includes buyer-aligned organizations that are commonly associated with radiation oncology technology, deployment, and evaluation. These are “sample buyer accounts” for targeting research and outreach planning. We can refine priorities further after reviewing your client website and product fit.

“Top 5 best samples to send first” (starter set)

1. Siemens Healthineers (Radiation Oncology / Varian ecosystem) — Siemens Healthineers: https://www.siemens-healthineers.com
2. Elekta — https://www.elekta.com
3. Accuray — https://www.accuray.com
4. RaySearch Laboratories — https://www.raysearchlabs.com
5. Brainlab — https://www.brainlab.com

Next Step (to finalize the best buyers for your client product)

Please share your client website URL and a one-sentence description of the product. After that, we will return a refined buyer shortlist tailored to the ASTRO ecosystem (with the most relevant industries and job titles), including which buyer groups we should prioritize most heavily.